38 Chapter 2 23. Nivel. Zorg door de huisarts 2022. Nivel Zorgregistraties Eerste Lijn: jaarcijfers 2021 en trendcijfers 2017–2021 [in Dutch]. https://www.nivel.nl/nl/publicatie/zorg-door-de-huisarts-nivel-zorgregistraties-eerste-lijn-jaarcijfers2021-en-0 24. Sullivan BA, Panda A, Wallman-Stokes A et al. Antibiotic spectrum index: a new tool comparing antibiotic use in three NICUs. Infect Control Hosp Epidemiol 2022: 43: 1553–7. 25. Leung V, Li M, Wu JH et al. Evaluating antimicrobial use and spectrum of activity in Ontario hospitals: feasibility of a multicentered point prevalence study. Open Forum Infect Dis 2018; 5: 110. 26. Singh P, Steurer MA, Cantey JB et al. Hospital-level antibiotic use and complexity of care among neonates. J Pediatr Infect Dis Soc 2020; 9: 656–63. 27. Yarrington ME, Wrenn RH, Spivey J et al. Measuring empiric antibiotic spectrum—a journey through space and time. Infect Control Hosp Epidemiol 2022; 28. Song S, Wilson BM, Marek J et al. Use of electronic pharmacy transaction data and website development to assess antibiotic use in nursing homes. BMC Med Inform Decis Mak 2021; 21: 148. 29. Thampi N, Shah PS, Nelson S et al. Prospective audit and feedback on antibiotic use in neonatal intensive care: a retrospective cohort study. BMC Pediatr 2019; 19: 105. 30. Savage TJ, Rao S, Joerger J et al. Predictive value of direct disk diffusion testing from positive blood cultures in a childrens hospital and its utility in antimicrobial stewardship. J Clin Microbiol 2021; 59: e02445-20. 31. Queenan K, Häsler B, Rushton J. A one health approach to antimicrobial resistance surveillance: is there a business case for it? Int J Antimicrob Agents 2016; 48: 422–7.
RkJQdWJsaXNoZXIy MTk4NDMw